Sign in

CIK 0000072444

  • Accelerated filer
  • Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
591212264
Phone
+1 650-550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-08-11 Fox James Director Grant or award +2,500 $2.49 $6K 2,500
2015-06-10 Fox James Director Purchase +70,000 $2.03 $142K 100,614
2015-06-09 Fox James Director Purchase +70,000 $1.99 $139K 100,614
2015-05-12 Fox James Director Grant or award +7,500 $2.20 $17K 7,500
2014-05-15 Fox James Director Grant or award +7,500 $2.85 $21K 7,500
2013-05-01 Fox James Director Grant or award +8,700 8,700
2013-05-01 Fox James Director Grant or award · Stock Option (Right to Buy) +15,000 15,000

Page 1 of 1 · 7 trades